Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125824771 | 12582477 | 1 | I | 20160508 | 20160509 | 20160722 | 20160722 | EXP | DE-TEVA-659558GER | TEVA | 49.49 | YR | F | Y | 125.00000 | KG | 20160722 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125824771 | 12582477 | 1 | PS | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | 20 MILLIGRAM DAILY; | N | 323K453810413 | 20622 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125824771 | 12582477 | 1 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125824771 | 12582477 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125824771 | 12582477 | Back pain | |
| 125824771 | 12582477 | Dyspnoea | |
| 125824771 | 12582477 | Feeling abnormal | |
| 125824771 | 12582477 | Hypersensitivity | |
| 125824771 | 12582477 | Immediate post-injection reaction | |
| 125824771 | 12582477 | Panic disorder | |
| 125824771 | 12582477 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125824771 | 12582477 | 1 | 20150522 | 0 |